Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Overview of attention for article published in New England Journal of Medicine, July 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 200 X posts from 182 X users, with an upper bound of 2,107,415 followers.

@mmctec @CatLSiegel @alroker One additional study proving superiority of apixaban over warfarin in DVT- the AMPLIFY trial. https://t.co/DjFAZzSR0I

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 196 additional X posts.